Treatment of these cancer cells with leupeptin, a protease inhibitor, and/or ALLM, a calpain specific inhibitor, blocks extracellular Ca++-mediated cleavage of FLNA and thereby reduces cellular migration in androgen receptor deficiency [37]. This evidence concerns the gene FLNA and cancer.